Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Stadler, H; Höllerl, G; Tscheliessnigg, KH.
Shock-treatment in gastro-intestinal-bleeding with 3,5% isocyanate crosslinked polypeptide solution
ANAESTHESIST. 1982; 31(7): 337-339.
Web of Science
PubMed
- Co-Autor*innen der Med Uni Graz
- Tscheliessnigg Karlheinz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- In a prospective study infusions of 3,5% isocyanate crosslinked polypeptide solution 500 ml (Haemaccel 3,5%) were given to patients with gastro-intestinal-bleeding for shock treatment and prophylaxis. The increase in intravascular volume was always satisfactory. We did not see any undesirable side effects (anaphylaxis, anaphylactoid reaction, coagulopathy, oliguria).
- Find related publications in this database (using NLM MeSH Indexing)
- Gastrointestinal Hemorrhage - drug therapy
- Humans - drug therapy
- Plasma Substitutes - adverse effects
- Polygeline - adverse effects
- Polymers - therapeutic use
- Prospective Studies - therapeutic use
- Shock, Hemorrhagic - drug therapy